Tazarodex
FDA Label NDC 73503-007

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Psodex Usa Inc for the product Tazarodex (NDC 73503-007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding tazarodex cream plaque psoriasis & acne, tazarodex cream plaque psoriasis & acne - directions, ​tazarodex cream plaque psoriasis & acne, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.